Ouro Fino Saúde Animal Participações S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
May 12, 2022
Share
Ouro Fino Saúde Animal Participações S.A. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was BRL 202.32 million compared to BRL 168.78 million a year ago. Net income was BRL 16 million compared to BRL 9.49 million a year ago. Basic earnings per share from continuing operations was BRL 0.29748 compared to BRL 0.17593 a year ago. Diluted earnings per share from continuing operations was BRL 0.29748 compared to BRL 0.17593 a year ago.
Ouro Fino Saude Animal Participacoes S.A., also known as Ourofino, is a Brazil-based company engaged in the animal health market business sector in Latin America. The Company manufactures veterinary products using scientific technology in the Company's laboratories. The Company's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.
OURO FINO SAÚDE ANIMAL PARTICIPAÇÕES S.A. 
